U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT06883656) titled 'The Pharmacokinetics Study of Fotagliptin in Patients with Different Degrees of Renal Insufficiency' on March 03.
Brief Summary: The trial was designed in a single dose, open, non-randomized, multi-dose parallel control group. The study of patients were mild and moderate renal insufficiency, and matched healthy subjects.
Study Start Date: March 15, 2022
Study Type: INTERVENTIONAL
Condition:
Type 2 Diabetes Mellitus (T2DM)
Renal Insuficiency
Intervention:
DRUG: SAL067
Fasting oral test drug 12mg
Recruitment Status: COMPLETED
Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.
Published by HT Digital Content Services with ...